Codexis Inc (CDXS) stock news · rev $70.4M
Codexis Inc (CDXS) is a biotechnology company listed on US.
This CDXS news page leads with what Codexis Inc filed — not a scraped headline mill.
No cached 8-K sentence for CDXS yet. We will not pad this page with generic market recap.
Latest reported CDXS revenue for 2025-12-31 was $70.4M. Net income was -$44.0M. Revenue was up 18.6% from 2024-12-31 to 2025-12-31. CDXS currently screens at market cap $257.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CDXS stock page; for the tape open the quote page.
CDXS stock news FAQ
What are CDXS's latest revenue and net income?
Latest cached Codexis Inc (CDXS) revenue for Dec 31, 2025 was $70.4M. Net income was -$44.0M. Statements: https://lician.com/financials/cdxs
How did CDXS revenue change from the prior cached period?
Cached Codexis Inc (CDXS) revenue was up 18.6% from $59.3M (Dec 31, 2024) to $70.4M (Dec 31, 2025). Statements: https://lician.com/financials/cdxs
What is CDXS's market cap?
Codexis Inc (CDXS) market cap is $257.6M on the latest cached fundamentals snapshot.
What kind of company is CDXS?
Codexis Inc (CDXS) is a biotechnology company listed on US.
Where is CDXS stock news listed?
Cached stock news for Codexis Inc (CDXS) is listed at https://lician.com/news/cdxs. Filings: https://lician.com/sec/cdxs
Not investment advice.